Skip to main content
. Author manuscript; available in PMC: 2013 Jun 17.
Published in final edited form as: N Engl J Med. 2008 Aug 14;359(7):697–708. doi: 10.1056/NEJMoa0800743

Figure 2. Cumulative Percentages of Patients with Breast Cancer and Stroke.

Figure 2

At 4 years, therapy with tibolone was associated with a decrease in the risk of invasive breast cancer (relative hazard, 0.32; 95% CI, 0.13 to 0.80; P=0.02) (Panel A) but with an increase in the risk of stroke (relative hazard, 2.19; 95% CI, 1.14 to 4.23; P=0.02) (Panel B).